quinoxalines has been researched along with u-50488 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacocks, HM; McMahon, PN; Werling, LL | 1 |
| Doan, P; Lutfy, K; Nugyen, M; Weber, E | 1 |
| Doan, P; Lutfy, K; Nguyen, M; Weber, E | 1 |
| Jackisch, R; Riegert, C; Rothmaier, AK; Rutz, S | 1 |
| Autar, R; Bouzanne des Mazery, R; Fröhlich, R; Molenveld, P; Schepmann, D; Soeberdt, M; Sterk, GJ; Storcken, RP; van der Haas, RN; van Oss, B; Wünsch, B | 1 |
5 other study(ies) available for quinoxalines and u-50488
| Article | Year |
|---|---|
Regulation of [3H]dopamine release from guinea pig striatum by NMDA receptor/channel activators and inhibitors.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Corpus Striatum; Dopamine; Glycine; Guinea Pigs; Ion Channels; Magnesium; Male; N-Methylaspartate; Piperazines; Pyrrolidines; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid | 1990 |
ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50,488H in the tail flick test in mice.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Drug Synergism; Excitatory Amino Acid Antagonists; Male; Mice; Morphine; Pain Measurement; Quinoxalines; Receptors, N-Methyl-D-Aspartate | 1998 |
Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Excitatory Amino Acid Antagonists; Glycine; Male; Mice; Nociceptors; Pain; Pain Measurement; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, kappa | 1999 |
Presynaptic modulation of 5-HT release in the rat septal region.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic alpha-Agonists; Analgesics, Non-Narcotic; Animals; Brimonidine Tartrate; Calcium; Dose-Response Relationship, Drug; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; In Vitro Techniques; Male; Neurons; Presynaptic Terminals; Pyridines; Pyrroles; Quinoxalines; Quipazine; Rats; Rats, Wistar; Septum of Brain; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 2007 |
Conformationally restricted κ-opioid receptor agonists: Synthesis and pharmacological evaluation of diastereoisomeric and enantiomeric decahydroquinoxalines.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Crystallography, X-Ray; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Molecular Structure; Piperazines; Protein Binding; Pyrrolidines; Quinoxalines; Receptors, Opioid, kappa; Stereoisomerism | 2015 |